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LIVING CELLS incubated in the non-
fluorescing fluorescein diacetate (FDA)
produce, byintracellular enzymatic hydro-
lysis, fluorescein, which on excitation with
polarized light of a given wavelength
fluoresces, emitting light of different
degrees of polarization over a range of
wavelengths. These fluorescence emission
polarization spectra, observed on excita-
tion at 470 nm, show wavelength-depen-
dent changes which are characteristic of
the physiological state of living cells. A
characteristic feature in normal cells in
the Go or G1 phases of the cell cycle is a
sharp emission polarization peak at 510
nm which disappears on their progression
into the DNA-synthesis phase (Cercek
et al., 1973, 1978). Recently, it has been
established that changes in this emission
polarization peak reflect alterations in the
structuredness of the mitochondria as a
result of their transition from the con-
densed to the orthodox conformation and
vice versa. The formation and disappear-
ance of the emission polarization peak at
510 nm (P510-peak) is therefore a marker
for the conformational changes in the
mitochondria in intact cells (Cercek &
Cercek, 1979).
We have reported that quantitative
changes in the intracellular fluorescein
fluorescence polarization of haemopoietic
cell lines treated with proliferation-in-
hibiting cell extracts can be used to study
the specificity and reversibility of the
effects of these substances (Lord et al.,
1974a, b). To qualify the changes induced
by these growth inhibitors we have now
studied the effects of lymph-node extracts
(LNE), granulocytic extracts (GCE) and
red-cell extracts (RCE) on fluorescein
emission polarization spectra of lympho-
cytes and the precursor cells of granulo-
cytes and red cells. The aim of this study
was to establish whether the growth-
inhibiting effects of these extracts could
be linked to the induction of structural
changes in the mitochondria (SCM).
Details of the technique for measure-
ment of the fluorescein fluorescence polar-
ization spectrum in living cells (Cercek
et al., 1978) as well as the preparation of
the LNE (Houck et al., 1971; Lord et al.,
1974a), GCE (Rytomaa & Kiviniemi,
1968; Lord et al., 1974a) and RCE (Kivi-
laakso & Rytomaa, 1971; Lord et al.,
1974a) extracts were the same as de-
scribed before. The haemopoietic cells
used were human peripheral SCM-respond-
ing lymphocytes (Cercek et al., 1978),
mouse femoral marrow cells and re-
generating spleen cells. Details of the
preparation of these cells were given pre-
viously (Lord et al., 1974a).
To test the LNE, SCM-responding
lymphocytes, which are normally in the
Go or G1 phase of the cell cycle, were first
incubated with phytohaemagglutinin
(PHA). These stimulated lymphocytes
were used as controls (Lord et al., 1974a, b).
The GCE was tested on mouse femoral
marrow cells, of which - 35% were pro-
liferating granulocytic cells. Since marrow
also contains erythrocyte precursor cells,L. CERCEK, B. CERCEK AND B. I. LORD
the RCE was also tested on these cells.
In addition, RCE was tested on the rapidly
proliferating erythrocyte precursors found
in the spleens of heavily irradiated mice
7 days after grafting with 106 normal
marrow cells (regenerating spleens). The
doses of LNE, GCE and RCE were the
same as those used in the earlier fluores-
cence studies (Lord et al., 1974a, b) and in
cell-proliferation studies (Lord, 1975;
Lord et al., 1977) i.e. 50 pg/ml of cell
suspension. As shown in Fig. 1, the
fluorescein emission polarization spectra
of the asynchronous populations of mouse
marrow cells, regenerating spleen cells
and human PHA-stimulated lymphocytes,
do not exhibit a polarization peak at
510 nm indicating that most of their
mitochondria are in the condensed con-
formation (Cercek & Cercek, 1979). This
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FIG. 1. Fluorescein emission polarization
spectra. A regenerating spleen cells: *,
control and *, RCE-treated cells. B--
SCM-responding lymphocytes: 0, control;
*, PHA-stimulated cells anl A, after
LNE treatment of PHA-stimulated cells.
C-marrow cells: 0, controls and *, after
RCE treatment. D marrow cells: *, con-
trols and *, after GCE treatment. The
error limits represent maximal deviations
from the mean value in 3 independent
experiments.
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FIG. 2. Effect of osmolality on the fluores-
cein emission polarization spectrum of
mouse marrow cells: *, 0-330 osmol/kg;
0, 0-596 osmol/kg. The experimental pro-
cedure was the same as described by Cercek
et al. (1978). The error limits represent
deviations from the mean value of 2
experiments.
absence of the P510 peak in asynchronous
populations appears to be due to an
activator produced by S-phase cells.
However, when these cells were incubated
for 45 min at 37°C with the growth-
inhibiting extract specific for the cell
type tested (LNE, GCE or RCE) the
respective fluorescein emission polariza-
tion spectra exhibited the sharp P510
peak. Since both GCE and RCE are shown
to be cell-line specific, their respective
net effects on the fluorescence polarization
spectra for normal marrow must be
expected to be less than if they were
tested on pure populations ofgranulocytic
or erythroid cells. Thus, the ratio of the
polarization values at 510 and 515 nm is
very much smaller for whole marrow
(Fig. IC) than for the population in
regenerating spleen (Fig. IA) though the
dosage and assay conditions were other-
wise the same. It has been demonstrated
before that the qualitative changes in the
fluorescence polarization spectra in living
cells are not caused simply by changes in
the intracellular water. The latter changes,
as well as those caused by changes in
temperature, induced only quantitative
wavelength-independent changes in the
emission polarization spectra (Cercek et
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al., 1978). Since GCE, RCE and LNE
induce an increase in the intracellular
fluorescein polarization (Lord et al., 1974a,
b) the effect of increasing osmolality (i.e.
decrease in the content of intracellular
water) on the emission polarization spectra
in mouse bone marrow cells was investi-
gated. Fig. 2 confirms that decreases in
intracellular water induce only wave-
length-independent changes in the emis-
sion polarization spectrum. No sharp
peak at 510 nm appears, which contrasts
with the effect ofgrowth inhibitors (Fig. 1).
These results indicate that the specific
haemopoietic growth inhibitors induce in
the fluorescein emission polarization
spectra of their precursor cells qualitative
wavelength-dependent changes which are
compatible with structural changes in the
mitochondria, viz. the transition into
their orthodox, idling-state conformation.
Since the transition to the orthodox con-
formation is usually accompanied by a
decrease in the rate of ATP production,
these effects of growth inhibiting extracts
on the structuredness of the energy-
producing domain appear to be involved
in the inhibitory and/or delaying effects of
the "chalones" on cell proliferation:
reduced labelling index, reduced flow
through the cell cycle, prolonged G1,
reduced cell production etc. (Houck et al.,
1973; Houck & Attalah, 1975; Lord, 1975;
Lord et al., 1977). The detailed mechanism
by which these cell-specific growth in-
hibitors induce structural changes in the
mitochondria has to be investigated. It
has been shown on isolated mitochondria
in the orthodox conformation and oni
normal synchronized cells in GU that
addition of 10-4M ofATP, ADP, succinate
(substrate) or pyruvate, (precursor sub-
strates) of the tricarboxylic acid (TCA)
cycle induce the disappearance of the
510 nm peak (Cercek & Cercek, 1979)
indicating the transition of mitochondria
into the switched-on, condensed conforma-
tion (Lehninger, 1975; Loewy & Siekevitz,
1974). As shown in Table I, the GCE-,
RCE- and LNE-induced 510 nm peak in
the emission polarization spectra of the
TABLE I. Abrogation of the RCE-, LNE-
and GCE-induced 510nm fluorescein
emission polarization peak
Polarization
ratio*
Cell system and treatment P510/P515
Regenerating spleen cells (RSC) 0-97
RSC +RCE (50 jig/ml) 1-60
RSC +RCE + 10-4MATP 1-02
RSC+RCE + 10-4MADP 1.08
RSC +RCE + 10-4 pyruvate 1 00
RSC+RCE + 10-4M succinate 0 99
Human lymphocytes (HL) + PHA 0-89
HL+LNE (50 ,ug/ml) 1-39
HL+LNE + 10-4MATP 1-06
HL+ LNE + 10-4m ADP 1-05
HL +LNE + 10-4M pyruvate 1 00
HL + LNE + 10-4M succinate 0.99
Marrow cells (BMC) 0.95
BMC+GCE (50 jug/ml) 1-33
BMC+GCE + 10-4MATP 1 06
BMC+ GCE + 10-4MADP 1-06
BMC +GCE + 10-4M pyruvate 0 97
BMC + GCE + 10-4M succinate 0.99
* P510/P515> 1-1 indicates a polarization peak.
TABLE II.-Effects of dinitrophenol (DNP
10-7M) and oligomycin (OM, 10-4M) on
the induction of the fluorescein fluores-
cence emissionpolarization peak by RCE,
LNE and GCE
Polarization
ratio*
Cell system and treatment P510/P515
Regenerating spleen cells (RSC) 0 97
RSC +DNP (or OM) 0-99
RSC +DNP (or OM) + RCE
(50 ,ug/ml) 1-01
Human lymphocytes (HL) + PH A 0-89
HL+PHA+DNP (or OM) 0-98
HL+ PHA+DNP (or OM) +
LNE (50 jug/ml) 0.99
Mouse bone marrow cells (BMC) 0.95
BMC +DNP (or OM) 0-96
BMC +DNP (or OM) + GCE
(50 ,ug/ml) 1-00
* No value > 1 1: No P510 peak.
respective precursor cell lines can also be
abrogated by the above substances. Fur-
thermore, the presence of substances
which do not revert the mitochondria into
the orthodox conformation, but are known
to uncouple the electron-transport chain
and/or oxidative phosphorylation (e.g.
10-7M dinitrophenol (DNP) and 10-4M
oligomycin,respectively(Lehninger, 1975))
prevents the induction of the 51Onm peak
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by GCE, RCE or LNE (Table II). These
results show that interference with the
TCA cycle prevents the transition of
mitochondria by the above growth in-
hibitors into the orthodox conformation.
However, the present data do not allow
us to decide whether the effects of these
growth inhibitors are caused by a selective
uptake into the respective precursor cells
followed by direct effects on the structural
changes in the mitochondria, thereby
affecting the rate of ATP production, or
by otherindirect processes such as modula-
tion of the adenylcyclase-phosphodi-
esterase system (Houck & Attalah, 1975).
Interference with the adenylcyclase-phos-
phodiesterase system has been shown be-
fore to induce changes in SCM (Cercek &
Cercek, 1974). Another tentative explana-
tion for the effect of the growth inhibitors
on SCM could be that a direct inhibition
of DNA synthesis by chalones (Houck
et al., 1973; Houck & Attalah, 1975;
Lord, 1975; Lord et al., 1977) might simul-
taneously stop the production of the
mitochondrial activator. Consequently,
the mitochondria of G1 cells in the
asynchronous population would revert to
the orthodox conformation, as reflected
in the P510 peak. However, more experi-
ments are needed to support any of the
above hypotheses.
In conclusion, changes induced by the
specific haemopoietic growth inhibitors
in the fluorescence emission polarization
spectra of their respective precursor cell
lines indicate that their inhibitory effects
on cellular processes are accompanied by
transient and reversible changes of the
mitochondria into the orthodox conforma-
tion, which thereby might modulate the
rate of ATP production in these cells.
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